Form 8-K - Current report:
SEC Accession No. 0001615219-20-000034
Filing Date
2020-03-27
Accepted
2020-03-27 16:35:59
Documents
3
Period of Report
2020-03-23
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K slrxform8-k03272020.htm 8-K 23237
2 EX-99.1 slrx4q2019pr03272020fi.htm EX-99.1 96045
3 image01.jpg GRAPHIC 28927
  Complete submission text file 0001615219-20-000034.txt   160420
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 20752300
SIC: 2834 Pharmaceutical Preparations